Abstract
The phenotype/genotype relationship of patients with transfusion-dependent thalassaemia (TDT) is particularly complex and variable, thus generating different levels of severity and of annual transfusion volume (ATV). In this study, we explored the role and the contribution of several factors potentially involved in determining mean ATV in a cohort of TDT patients which have been followed since long time. We collected data on one-hundred and twenty-seven patients with transfusion-dependent β-thalassaemia followed at Rare Blood Cell Disease Unit, AORN Cardarelli Hospital. Age at first transfusion, genotype, spleen status (splenectomy or not), and mean soluble transferrin receptor (sTfR) were the parameters included in the analysis. At stepwise regression analysis which included all the parameters, only splenectomy and mean sTfR significantly predicted the mean ATV (F = 70.94, P < 0.0001, R2 = 0.540). Overall, our data may suggest that in patients with TDT, the measurement of sTfR level together with the spleen status could contribute, more accurately than genotype, to provide a basal evaluation of residual erythropoietic activity and mean ATV.
Similar content being viewed by others
References
Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C, Barella S, Cao A, Galanello R (1995) Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol 89(3):473–478
Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:11
Bayanzay K, Alzoebie L (2016) Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. J Blood Med 7:159–169
Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA (2013) Non-transfusion-dependent thalassemias. Haematologica 98(6):833–844
Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V (2013) Guidelines for the management of non transfusion dependent thalassaemia (NTDT) [Internet]. Thalassaemia International Federation, Nicosia, Cyprus
Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V (2014) Guidelines for the management of transfusion dependent thalassaemia (TDT) [Internet], 3rd edn. Thalassaemia International Federation, Nicosia (CY)
Ricchi P, Ammirabile M, Costantini S, Spasiano A, Cinque P, Gargiulo B, Filosa A (2019) Longitudinal trend analysis of serum transferrin receptor-1 level in a cohort of patients affected by non-transfusion dependent thalassaemia. Br J Haematol 186(5):e121–e123
Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61–76
Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Cinque P, Pagano L, Prossomariti L (2009) Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients. Eur J Haematol 82(3):219–222
Quinn GP, Keough MJ (2002) Experimental design and data analysis for biologists. In: Press CU (ed) vol
Cappellini MD, Porter JB, Viprakasit V, Taher AT (2018) A paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies? Blood Rev 32(4):300–311
Danjou F, Anni F, Perseu L, Satta S, Dessi C, Lai ME, Fortina P, Devoto M, Galanello R (2012) Genetic modifiers of beta-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica 97(7):989–993
Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood 118(13):3479–3488
Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Pepe A, Cinque P, Pagano L, Casale M, Filosa A, Prossomariti L (2014) Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia. Blood Transfus 12(Suppl 1):s124–s130
Casale M, Cinque P, Ricchi P, Costantini S, Spasiano A, Prossomariti L, Minelli S, Frega V, Filosa A (2013) Effect of splenectomy on iron balance in patients with beta-thalassemia major: a long-term follow-up. Eur J Haematol 91(1):69–73
Sharma A, Easow Mathew M, Puri L (2019) Splenectomy for people with thalassaemia major or intermedia. Cochrane Database Syst Rev 9:CD010517
Ricchi P, Meloni A, Spasiano A, Neri MG, Gamberini MR, Cuccia L, Caruso V, Gerardi C, D’Ascola DG, Rosso R, Campisi S, Rizzo M, Terrazzino F, Vangosa AB, Chiodi E, Missere M, Mangione M, Positano V, Pepe A (2015) Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients. Am J Hematol 90(11):1008–1012
Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Verna R, Pepe A, Cinque P, Saporito C, Filosa A, Pagano L (2016) Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study. Blood Transfus 14(6):538–540
Ricchi P, Meloni A, Costantini S, Spasiano A, Di Matola T, Pepe A, Cinque P, Filosa A (2017) Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia. Ann Hematol 96:1541–1546
Garbowski MW, Evans P, Vlachodimitropoulou E, Hider R, Porter JB (2017) Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin. Haematologica 102(10):1640–1649
Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarre C, Beuzard Y, Chretien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M (2018) Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med 378(16):1479–1493
Acknowledgments
We thank all patients for their cooperation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study complied with the Declaration of Helsinki. All patients gave written informed consent to the protocol. The study was approved by the Ethics Committee of the Cardarelli-Santobono-Pausilipon Hospital, Napoli, Italy.
Conflict of interest
A.P. is the PI of the MIOT project that receives “no-profit support” from industrial sponsorships (Chiesi Farmaceutici S.p.A., ApoPharma Inc. and Bayer). The remaining authors have nothing to disclose.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ricchi, P., Meloni, A., Costantini, S. et al. Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors. Ann Hematol 99, 1209–1215 (2020). https://doi.org/10.1007/s00277-020-04047-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-04047-w